Gossamer Bio logo

Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical public company developing products and therapies in the areas of immunology, inflammation, fibrosis and oncology.

2

Funding Rounds

$330.0m

Money raised

Overview

Gossamer Bio is a clinical-stage biopharmaceutical public company developing products and therapies in the areas of immunology, inflammation, fibrosis and oncology.

Funding

Funding series

Funding Series Analysis

The company Gossamer Bio has raised a total of $330m in funding over 2 rounds.

Key Insights:

  • Gossamer Bio Series B round, July 2018: $230m
  • Gossamer Bio Series A round, January 2017: $100m
Gossamer Bio logo
Gossamer Bio Series B round, July 2018 $230m
Gossamer Bio logo
Gossamer Bio Series A round, January 2017 $100m

Industries

Gossamer Bio is active in the following industries:
  • Biology
  • Biomedical engineering
  • Technology
  • Biotechnology
  • Healthcare
  • Engineering